Canine thymus cells infected with virus (HL-23 V) produced by human acute myelogenous leukaemia cells in culture were shown in previous reports to produce transforming and non-transforming type C virus similar or identical to the simian sarcoma virus complex SSV(SSAV) and to induce tumours in marmoset monkeys (Bergholz et al. I977a). In these earlier studies the appearance of breakthrough foci at low dilutions of antiserum in neutralization tests with high-titred anti-SSV(SSAV) serum suggested the presence of another virus, distinct from SSV-(SSAV). We now report the isolation of this component and, by comparative neutralization analysis, demonstrate that it is most closely related to gibbon ape leukaemia virus (GALV). It is distinguished from SSV(SSAV) by kinetics of neutralization and molecular hybridization experiments. This component was readily cloned both from virus produced by HL-23 V chronically-infected canine thymus cells established by Teich et al. (1975) when HL-z3V was first isolated and from virus produced by HL-z3V-induced marmoset tumour cells in culture. The presence of this component in the original leukaemic cell cultures is discussed.
INTRODUCTION
Cultured human peripheral leucocytes and bone marrow cells from a patient (HL-23) with acute myelogenous leukaemia released type C virus which was transmissible to secondary cell culture lines (Gallagher & Gallo, I975; Teich et al. I975 )-One of these secondary cell cultures, used as a source of virus for further characterization, was a canine thymus cell line (A7573/HL-23V). Previous studies demonstrated that A7573/HL-23V cells produced both transforming and non-transforming virus which was closely related or identical to the simian sarcoma-simian associated virus complex, SSV(SSAV) and induced virus-producing fibromas in newborn marmosets (Bergholz et al. I977a) . As reported previously, cells in cultures established from biopsied tissue of an HL-z3V-induced marmoset tumour produced transforming virus (BF/HL-23 V) at passage 4 in vitro which was biooo22-t317/8o/oooo-3825 $02.00 © 198o SGM logically and antigenically indistinguishable from SSV(SSAV) (Bergholz et al. I977a ) . It was also noted at that time that HL-23V produced by canine thymus or marmoset tumour cells yielded breakthrough loci when reacted with low dilutions of anti-SSV(SSAV) or anti-HL-23V serum, in contrast to SSV(SSAV) which never yielded breakthrough foci at low dilutions of antiserum. We now report in an extension of these studies that cloning of virus produced by HL-23 V breakthrough loci resulted in the isolation of another HL-23 virus component, one closely related or identical to gibbon ape leukaemia virus (GALV). GALV, a primate type C virus associated with naturally occurring lymphoma and leukaemia in gibbons, is closely related to SSV(SSAV) but has distinct pi2 and virus envelope protein antigenic determinants and extensive but incomplete genome homology (Benveniste & Todaro, 1973; Parks et al. 2973; Hino et al. 2975; Tronick et al. 2975; Sun et al. I978) .
METHODS

Cells and viruses.
Marmoset foetal skin (MFS) and human foreskin fibroblast (HFF) cell cultures were established in the Department of Microbiology at Rush-Presbyterian-St Luke's Medical Center, Chicago, II1., U.S.A. Marmoset tumour cell cultures producing virus designated BF/HL-23V in this report were established from HL-23V-induced tumour tissue as described previously (Bergholz et al. I977a) . Cell cultures were maintained on medium RPMI-164o (Gibco, Grand Island, N.Y., U.S.A.) supplemented with lO% (heatinactivated) foetal calf serum (FCS; Reheiss Chemical Co., Phoenix, Ariz., U.S.A.). HL-23V chronically infected canine thymus cells (A7573/HL-23V), established by Teich et al. (I975) , were maintained in Eagle's basal medium improved with non-essential amino acids (Gibco) and supplemented with io% FCS. A7573/HL-23V ceils at passage t 7 were received at Rush-Presbyterian-St Luke's Medical Center in February ~975, for evaluation of HL-23 V oncogenicity. A7573/HL-23V virus-containing culture fluids stored I week after arrival of the cell culture were used for cloning experiments. A7573/HL-23V and marmoset tumour cells were handled in a laboratory remote from primate retrovirus work. Virus cloned from HL-z3V-induced marmoset turnout cells or A7573/HL-z3V cells was propagated in MFS or HFF cells. SSV(SSAV) was obtained from supernates of continuously passaged SSV(SSAV)-transformed marmoset cells [HF/SSV(SSAV)] or 7r-AP-I marmoset tumour cells as described previously (Bergholz et al. 1977a ) . SSV(SSAV) is a complex of transforming virus (SSV) and a to-to loo-fold excess of non-transforming associated virus (SSAV) (Wolfe et al. ~972). Baboon endogenous virus (BaEV) from Papio anubis, grown in canine thymus cells (455-K/A7573-FCfzth) and BaEV (M7) from Papio cynocephalus, also grown in canine thymus cells, were obtained from HEM, Inc., Bethesda,~Md., U.S.A. and from the Frederick Cancer Research Center, respectively. GALV was obtained from supernates of marmoset ceils chronically infected with GALV produced by a continuous lymphoblastoid cell line established from tumour tissue of a gibbon ape from the San Francisco Zoo with lymphoma and supplied by Dr T. Kawakami (Kawakami et aL i972 ) . This strain of GALV has sometimes been referred to as GALV-SFMC. GALV pseudotypes of SSV were produced by GALV rescue of the sarcoma genome from SSV-transformed non-producer marmoset cells (Bergholz et al. 1977b) . Virus stocks contained comparable ratios of transforming to nontransforming virus as demonstrated by interference tests.
Antisera. SSV(SSAV) neutralizing antiserum was prepared by hyperimmunization of a goat with autologous SSV(SSAV)-transformed goat cells. Analysis of the specificity of this antiserum by radio-immunoprecipitation and gel electrophoresis demonstrated reactivity against SSAV gp69/7I and prz(E)/pI5(E), but not p3o or plo (Deinhardt et al. i978) .
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Goat anti-BF/HL-z3V was prepared in the same manner. GALV neutralizing antiserum was obtained from a marmoset inoculated with GALV-producing lymphoblastoid cells derived from a gibbon ape with lymphoma (Kawakami et al. 1972) . Marmoset anti-SSV-(SSAV) serum was obtaivLed from an animal inoculated intracerebrally with cell-free SSV(SSAV) Antisera used in immunodiffusion tests included goat anti-SSV(SSAV) p3 o and goat anti-Rauscher murine leukaemia virus (MuLV) p3o, kindly provided by Dr T. August, and goat antisera prepared against Tween-ether-disrupted feline leukaemia virus (FeLV), p28 of BaEV and undisrupted BaEV, obtained through the Office of Program Resources and Logistics of the Virus Cancer Program. Virus assays. Transforming virus was assayed by focus induction on normal marmoset or human cells as described previously (Bergbolz et al. t977a) . For demonstration of nontransforming virus, normal marmoset cells infected at dilutions beyond the focus endpoint were subcultured and tested for virus production by assay of supernatant medium for reverse transcriptase activity (Bergholz et al. I977 b) and by interference with SSV focus induction.
Neutralization tests. Neutralization of transforming virus was determined by measuring inhibition of focus formation on MFS or HFF cells. Constant amounts of virus (too f.f.u. per antiserum dilution tested) were mixed with antiserum and incubated for 4 h at 4 °C as described previously (Bergholz et al. ~977a) . That dilution of antiserum which inhibited focus induction > 5o%, relative to controls incubated without antiserum, represented the neutralization titre. For determination of kinetics of neutralization virus at a final concentration of zoo f.f.u./ml was mixed with antiserum in Hanks' balanced salt solution containing o/ agamma FCS and held on ice. Aliquots were withdrawn at 5/¢g/ml polybrene and 2/o 6o rain intervals. Surviving fraction (Vs/Vo), relative to virus tested in parallel in the absence of antiserum (Vo), was measured by focus assay.
Preparation of nucleic acids. Virus all-labelled complementary DNA (cDNA ; 2oooo ct/ min//~g) was prepared from detergent-disrupted virions as described previously (Reitz et al. t976) except that the reaction was approx. I mM in aH-dATP, aH-dGTP, aH-dCTP and aH-dTTP. RNA was prepared from supernatant solutions of ceil homogenates centrifuged at rooog for ro rain, followed by Pronase-SDS digestion and phenol:cresol:chloroform extraction as described elsewhere (Wu et al. t974) . Cell DNA was prepared from nuclei or from whole cells or tissues by Pronase-SDS digestion, phenol :cresol : chloroform extractions and alkali digestion as detailed earlier (Reitz et al. 1976) . Virus RNA was prepared either as 7oS RNA by velocity gradient sedimentation (Reitz et al. 1976) or poly(A)-containing virus RNA by oligo(dT)-cellulose chromatography (Smith et al. 1976) .
Molecular hybridization. Hybridization of aH-cDNA to RNA was performed in 5o% formamide-o'45 M-NaCI at 37 °C and expressed as a function of CJ in tool s/1 (Birnsteil et al. T972) , uncorrected for salt, temperature or solvent. Hybridization was assayed by digestion with St nuclease as detailed elsewhere (Reitz et al. 1976) . Virus RNA was used at I #g/I2o#l with 5 × m -5 to 2"5× m-~#g aH-cDNA and cell RNA was present at Ioo to 2oo/~g/rzo/d. Hybridization of aH-cDNA to cell DNA was performed with at least a mY-fold excess of DNA at 6o °C in 0.36 M-NaC1. Hybridization was assayed by St nuclease digestions.
RESULTS
Cloning A7573/HL-23 V breakthrough loci
Previous neutralization studies (Bergholz et al. ~977a ) demonstrated that A7573/HL-z3V and SSV(SSAV) yielded identical o/ 5 °/o neutralization endpoints in experiments with marmoset anti-SSV(SSAV) serum and two-to fourfold differences in endpoints in experiments with high-titred goat anti-SSV(SSAV) sera, a difference generally not considered (0) by goat anti-SSV(SSAV) diluted r :5o0 (--) or I : mo (---). Surviving virus (Vs) was determined by focus assay on HFF cells and compared to virus incubated without antiserum (Vo) as described in Methods.
significant. However, when the neutralization profiles of SSV(SSAV) and A7573/HL-E3V were compared by plotting surviving fraction versus antiserum dilution, a difference in neutralization patterns was apparent and suggested a heterogeneous virus population. To further compare SSV(SSAV) and virus produced by A7573/HL-z3V cells, kinetics of neutralization were determined by measuring inhibition of focus induction with time of incubation in the presence of a t: 5o0 dilution of goat anti-SSV(SSAV) serum. The results shown in Fig. t again suggested a difference in envelope properties of HL-z3V and/or a mixed population of viruses.
To determine whether A7573/HL-z3V cells produced virus distinct from SSV(SSAV) as well as virus indistinguishable from SSV(SSAV), virus produced by breakthrough loci appearing at low dilutions of anti-SSV(SSAV) serum was sequentially cloned. As A7573/ HL-23 V ceils were known to contain proviral sequences related to BaEV as well as SSV-(SSAV)-related sequences (Chart et al. I976; Okabe et al. I976), cloned HL-23 V was sequentially passed in marmoset cells to avoid the possible isolation of BaEV pseudotypes of SSV. Previous studies in this and other laboratories failed to demonstrate replication of BaEV or RD114 virus in marmoset cells infected with cell-free virus or fused with virusproducing cells (Bergholz et al. t977b) .
Cloned HL-23V was compared with SSV(SSAV) by kinetics of neutralization experiments. At a I: too dilution of antiserum, SSV(SSAV) was completely neutralized after 60 min exposure whereas HL,23 V, cloned as described above, was not neutralized after 4 h (Fig. I) . Previous studies demonstrated that only 8 o/io of uncloned A7573/HL-23V survived at this antiserum ~lilution, i~ contrast to the ~oo°/,, survival with the HL-z3V cloned virus. The results indicated that A7573/HL-z3 V cells produced a mixed population of viruses and that the virus cloned was present as a minor HE-z3 V component distinct from SSV(SSAV).
Cloning virus from marmoset tumour cells
Although a cell culture established from biopsy-derived tissue of an HL-23V-induced marmoset turnout initially yielded virus (BF/HL-z3V) indistinguishable from SSV(SSAV) in neutralization tests, virus harvested at later passages was neutralized only by much lower dilutions of anti-SSV(SSAV) serum (Table I) . Virus produced by a cell culture established from tumour tissue removed at autopsy of the same marmoset (75-BF-O was also compared to SSV(SSAV) in neutralization tests. Marmoset 75-BF-r plasma ob'tained at 3 months p.i. Uninfected o'9 > 25o > 300 5I
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* Normal marmoset cells were infected with lo-fold dilutions of BF/HL-z3V as described in Methods. Focus-free cultures were subcultured. Interference was measured by inhibition of focus induction following challenge with transforming virus.
t The ratio (rA/dA) of 8H-TTP ct/min incorporated in a reverse transcriptase (RT) assay with synthetic poly(rA), oligo(dt) and poly(dA), oligo(dT).
:~ NT, Not tested.
which neutralized SSV(SSAV) at a dilution of 1:8t92, yielded a 50 % neutralization endpoint of I : 32 with virus produced by the autopsy-derived tumour cell culture. Before further characterization, BF/HL-23V-transforming virus was sequentially cloned as described for A7573/HL-23V. Of 4o clones tested during the sequential cloning, all yielded virus with 5o% neutralization endpoints at low dilutions of antiserum (i :32 to 1:64) relative to SSV(SSAV) (1:1o24). Only cloned BF/HL-23 V was used in experiments aimed at characterizing the properties of BF/HL-23V.
Non-transforming associated virus
Non-transforming virus associated with cloned BF/HL-23V and cloned A7573/HL-23V was isolated by infection of normal marmoset cells with virus diluted beyond the focus endpoint. At least a loo-fold excess of non-transforming virus was detected by assay of culture fluids for reverse transcriptase activity (Table z) 
lmmunodiffusion tests
For comparison of the antigenic properties of the major internal structural protein, p3o, of cloned HL-z3V with those of other mammalian retrovirus p3os, cloned HL-z3V nontransforming virus was concentrated by centrifugation, detergent-disrupted and reacted in immunodiffusion tests with antisera prepared against SSV(SSAV), FeLV, MuLV or BaEV p3o. A line of identity appeared between the cloned HL-z3V, SSV(SSAV) and uncloned A7573/HL-23V antigen preparations precipitated by anti-SSV(SSAV) p3o serum, demonstrating that the HL-23 V cloned in these studies had a p3o antigenically related or identical to that of SSV(SSAV). The cloned HL-z3V antigen preparations were not precipitated by antisera specific for the major structural proteins of FeLV, BaEV, RDtI4 or Rauscher MuLV.
Comparison with SSV(SSA V) by molecular hybridization
The relatedness of BF/HL-23V and SSV(SSAV) was explored by molecular hybridization techniques. When an SSV(SSAV) cDNA was reacted with SSV(SSAV) or BF/HL-z3V virus RNA 77% homology with BF/HL-z3V RNA was demonstrated (Fig. 2) . In the reciprocal experiment, 78% of BF/HL-z3V eDNA was hybridized with polyadenylated SSV(SSAV) RNA (Fig. 4) . These differences were observed repeatedly in experiments performed independently in two laboratories. Cytoplasmic RNA from BF/HL-23 Vinfected cells hybridized 88% of the BF/HL-23 V eDNA and 75% of the SSV(SSAV) cDNA (data not shown). In DNA-DNA reassociation experimer~ts, BF/HL-z3V cDNA yielded 34% hybridization with BF/HL-z3V-infected cell DNA and 2T °/, hybridization with SSV(SSAV)-infected cell DNA at an uncorrected Cot of 8ooo mol s/1. SI resistance of cDNA-DNA at zero time was subtracted and percent hybridization was also corrected for cDNA self-annealing with chick embryo DNA. These results indicated a difference between BF/HL-23V and SSV(SSAV) nucleic acid sequences.
Tests for endogenous virus relatedness
Molecular hybridization tests were performed to investigate the presence of BaEV-related sequences in BF/HL-z3V. As shown in Fig. 2 , no appreciable hybridization was demonstrated when BaEV cDNA was reacted with BF/HL-23V RNA. Likewise, BF/HL-z3V cDNA did not hybridize significantly with BaEV RNA (Fig. 3) . When BF/HL-23 V cDNA was hybridized to a mixture of SSV(SSAV) RNA and BaEV RNA, there was no increase in hybridization over that with SSV(SSAV) RNA alone (Fig. 4) , again indicating that BF/HL-z3V was not derived by interaction of the SSV(SSAV)-related component with BaEV-related sequences present in A7573/HL-E3V cells. Molecular hybridization studies have demonstrated that endogenous retroviruses of Old and New World primates are present in normal host cell DNA at zo to 50 copies per haploid genome (Benveniste & Todaro, T978; Todaro et al. I978) . To further explore the possibility that BF/HL-z3V may have been partially derived from endogenous virus sequences, a BF/HL-z3V cDNA was also reacted with DNAs of several New World primate species, including marmoset and woolly monkey, as well as DNA from Old World monkeys and apes, including baboon and gibbon. Hybridizations were carried out to an uncorrected Cot of 8ooo and analysed by SI nuclease resistance as described in Methods. Percent hybridization was corrected for S I resistance at zero time and for cDNA selfannealing (II'7%) determined by SI resistance in a reaction with chick embryo DNA. While BF/HL-23V cDNA hybridized 36% to DNA-extracted BF/HL-z3V cells, a level comparable to that observed in reactions with SSAV cDNA when SSAV sequences are present at t to a copies per haploid cell genome, there was no significant hybridization to DNA of any uninfected primate and therefore no evidence for BF/HL-z3V genetic sequences related to a non-human primate endogenous virus.
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Failure to detect BaEV-related sequences correlated with results of previous studies (Bergholz et al. I977a) in which BaEV p3o could not be detected in marmoset 75-BF-I tumour cells by radio-immunoassay or immurtodiffusion tests. In addition, BF/HL-23 V was not neutralized by a 1:5 dilution of anti-BaEV serum which titred I :2o as measured by inhibition of focus induction in mink lung S+L -cells. When neutralizing anti-BaEV and anti-SSV(SSAV) sera were mixed, neutralization was not enhanced beyond levels observed with anti-SSV(SSAV) serum alone. Although one cannot completely exclude the possibility of a recombinant or envelope-mosaic particles, there was no evidence of endogenous virus-derived BF/HL-z3V genetic sequences or proteins. 
Comparison of patterns of neutralization with SSV and GAL V
Hybridization data, together with immunologic data, suggested that BF/HL-z3V was closely related to SSV(SSAV) but had distinct envelope properties. These characteristics were similar to the differences observed between SSV(SSAV) and GALV and suggested that the antigenic relatedness of the envelope proteins of BF/HL-z3V and cloned A7573/HL-z3V should be compared to those of GALV in an assay which would distinguish between SSV(SSAV) and GALV. This was achieved by neutralization experiments in which the results were analysed by plotting surviving fraction versus antiserum dilution. Using this approach, SSV(SSAV) and GALV were clearly distinguished by patterns of neutralization with goat anti-SSV(SSAV) serum (Fig. 5) . It was also apparent that cloned BF/HL-23 V and A7573/HL-z3V yielded patterns distinct from that of SSV(SSAV), but identical to each other and very similar, if not identical, to the pattern of neutralization of SSV(GALV). Similarly, when analysed by neutralization with marmoset anti-GALV serum, the HL-23 V component cloned from A7573/HL-z3V cells or HL-z3V-induced marmoset tumour cells was indistinguishable from GALV, while SSV(SSAV) yielded a different pattern of neutralization (data not shown). When kinetics of neutralization with a I : 5oo dilution of marmoset anti-GALV were investigated (Fig. 6) , BF/HL-23 V and SSV(GALV) yielded similar patterns with 18 to 22 °,/o survival after 4 h compared to Ioo % survival of SSV(SSAV). A neutralizing antiserum prepared against BF/HL-23 V by immunization of a goat with autologous BF/HL-z3V-transformed cells was tested for reactivity against these same viruses. Again the neutralization profile (data not shown) indicated that BF/HL-z3V was more closely related to GALV than to SSAV.
When uncloned BF/HL-z3V produced at passage r5 of the biopsy-derived tumpur cell culture was reacted with a mixture of anti-GALV and anti-SSV(SSAV) sera of equal titres, BF/HL-23 V was completely neutralized (Vs/Vo < o.oI) at a t :256 final dilution of each antiserum. In contrast, at this same dilution of anti-SSV(SSAV) or anti-GALV alone, Vs/Vo values of o.82 and o.2, respectively, were demonstrated. These data are compatible with the finding that HL-z3V, uncloned, was a mixed population of GALV-and SSAV-related viruses.
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DISCUSSION
Results of studies reported here demonstrate that in addition to an SSV(SSAV)-related component, A7573/HL-23V cells produced low levels of virus closely related to GALV-SFMC. The results also indicate, for reasons that are not clear, that the HL-23V-induced marmoset tumour in culture produced the GALV-related component in excess of the SSV(SSAV)-related component. The fact that a previously undetected component was identified in these studies can be attributed in part to the presence of the transforming virus component, which led to the formation of pseudotypes, in part to the preferential growth of the GALV-related component in the marmoset tumour and to the use of neutralization experiments which distinguished SSV(SSAV) from GALV and facilitated detection and isolation of a minor virus component.
Passage of SSV(SSAV) in vitro in cells derived from a number of species including marmoset, dog and human and in vivo in marmosets has not altered its neutralization profile, characterized by the absence of breakthrough loci at low dilutions of high-titred antiserum and a clear-cut 50 % endpoint, suggesting that SSV(SSAV) has remained homogeneous since its isolation and that the env gene and glycoprotein are stable. Studies of gibbon type C virus strains have shown that each differs in sequence homology and that the genomes were unaltered by passage in vivo or in vitro (Sun et al. I978) . These observations indicate that it is unlikely that the previously unrecognized HL-23V component isolated from the marmoset turnout and A7573/HL-z3V cells arose by mutation or host-induced modification of the SSV(SSAV)-related component of HL-23V.
The GALV-related component isolated in these studies is apparently not unique to the particular HL-23V-infected cell culture evaluated for oncogenecity in marmosets and therefore not a result of virus contamination at Rush-Presbyterian-St Luke's Medical Center. Neutralization tests performed at the National Cancer Institute (NCI) have confirmed the presence of a minor HL-23V-transforming virus component, related but distinct from SSV(SSAV), in several virus pools stored frozen and retained at NCI (R. Gallagher & P. Markham, personal communication) . Neither the HL-23 leucocyte cell culture fluids with which A7573 cells were inoculated, A7573/HL-23 V cells, nor A7573/HL-23V virus stocks from which SSV(SSAV)-and GALV-related components were isolated had been stored in liquid nitrogen where cross-contamination could possibly occur. It is of interest that virus pools harvested from NC37 human cells and bat lung cells co-cultured with HL-23V peripheral leucocytes yielded RNA fingerprints identical to that of GALV-SFMC and distinct from SSV(SSAV) or other strains of GALV (W. Haseltine & B. Sahagan, personal communication). These GALV-containing virus stocks were obtained following the third and fifth passages of these HL-23 co-cultures, respectively. Thus, there can be little doubt that a GALV-related virus was present but previously undetected in more than one HL-23V-infected cell culture.
At present, it is impossible to prove whether uncultured cells from patient HL-23 contained GALV-related information. Reverse transcriptase related to the SSV(SSAV)-GALV group was demonstrated in uncultured and cultured peripheral blood cells of patient HL-23 and again a bone marrow-derived culture established at a later date , but this test for virus identification would not distinguish SSV(SSAV) from GALV. Similarly, detection of a minor GALV-related component in previously reported studies which utilized molecular hybridization techniques (Chart et al. I976; Okabe et al. 1976; Reitz et al. 1976) was limited both by the sensitivity of the assays and by the high degree of homology between SSV(SSAV) and GALV. Further studies are aimed at comparing the GA LV-related H L-a3V component to other strains of GALV.
